azacitidine has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alqinyah, M; Hooks, SB | 1 |
| Basavarajappa, BS; Nagre, NN; Shivakumar, M; Subbanna, S | 1 |
1 review(s) available for azacitidine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.
Topics: Animals; Azacitidine; Benzodiazepines; Cardiovascular Diseases; Drugs, Investigational; Epigenesis, Genetic; GTP-Binding Proteins; Humans; Hydroxamic Acids; Neoplasms; Neurodegenerative Diseases; Olanzapine; Protein Processing, Post-Translational; RGS Proteins; Signal Transduction; Vorinostat | 2018 |
1 other study(ies) available for azacitidine and Neurodegenerative Diseases
| Article | Year |
|---|---|
A single day of 5-azacytidine exposure during development induces neurodegeneration in neonatal mice and neurobehavioral deficits in adult mice.
Topics: Animals; Animals, Newborn; Azacitidine; Brain; Brain Diseases; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurodegenerative Diseases; Phosphopyruvate Hydratase; Receptor, Cannabinoid, CB1; Signal Transduction; Social Behavior | 2016 |